FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

LSV Associates, LLC
2. Issuer Name and Ticker or Trading Symbol

ALX ONCOLOGY HOLDINGS INC [ ALXO ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

C/O LSV CAPITAL MANAGEMENT, LLC, 2884 SAND HILL ROAD, SUITE 121
3. Date of Earliest Transaction (MM/DD/YYYY)

7/21/2020
(Street)

MENLO PARK, CA 94025
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

___ Form filed by One Reporting Person
_ X _ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 7/21/2020  C  1831027 A (1)(2)(3)2268087 (4)I See footnote (5)
Common Stock 7/21/2020  C  249632 A (1)(2)(3)309222 (6)I See footnote (7)
Common Stock 7/21/2020  P  378000 A$19.00 378000 I See footnote (8)
Common Stock 7/21/2020  C  1498984 A (1)(2)(3)2023469 (9)I See footnote (8)
Common Stock 7/21/2020  P  22000 A$19.00 22000 I See footnote (10)
Common Stock 7/21/2020  C  111528 A (1)(2)(3)120212 (11)I See footnote (10)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Series A Convertible Preferred Stock  (1)7/21/2020  C     1633743   (1) (1)Common Stock 1633743  (1)0 I See footnote (5)
Series A Convertible Preferred Stock  (1)7/21/2020  C     222752   (1) (1)Common Stock 222752  (1)0 I See footnote (7)
Series A Convertible Preferred Stock  (1)7/21/2020  C     683523   (1) (1)Common Stock 683523  (1)0 I See footnote (8)
Series A Convertible Preferred Stock  (1)7/21/2020  C     39758   (1) (1)Common Stock 39758  (1)0 I See footnote (10)
Series B Convertible Preferred Stock  (2)7/21/2020  C     59998   (2) (2)Common Stock 59998  (2)0 I See footnote (5)
Series B Convertible Preferred Stock  (2)7/21/2020  C     8175   (2) (2)Common Stock 8175  (2)0 I See footnote (7)
Series B Convertible Preferred Stock  (2)7/21/2020  C     150801   (2) (2)Common Stock 150801  (2)0 I See footnote (8)
Series B Convertible Preferred Stock  (2)7/21/2020  C     11110   (2) (2)Common Stock 11110  (2)0 I See footnote (10)
Series C Convertible Preferred Stock  (3)7/21/2020  C     137286   (3) (3)Common Stock 137286  (3)0 I See footnote (5)
Series C Convertible Preferred Stock  (3)7/21/2020  C     18705   (3) (3)Common Stock 18705  (3)0 I See footnote (7)
Series C Convertible Preferred Stock  (3)7/21/2020  C     664660   (3) (3)Common Stock 664660  (3)0 I See footnote (8)
Series C Convertible Preferred Stock  (3)7/21/2020  C     38660   (3) (3)Common Stock 38660  (3)0 I See footnote (10)

Explanation of Responses:
(1) Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
(2) Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
(3) Each share of Series C Convertible Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date
(4) Includes 437,060 shares of Common Stock issued as payment of accrued dividends upon conversion of the preferred stock on July 21, 2020.
(5) The shares are held of record by Lightstone Ventures, LP (LV LP). LSV Associates, LLC (LSV Associates), the General Partner of LV LP, and Michael A. Carusi, Jean M. George and Henry A. Plain, Jr., the individual managing directors of LSV Associates, share voting and dispositive power with respect to the shares held of record by LV LP, but each disclaims beneficial ownership of such shares except to the extent of his, her or its individual pecuniary interest therein.
(6) Includes 59,590 shares of Common Stock issued as payment of accrued dividends upon conversion of the preferred stock on July 21, 2020.
(7) The shares are held of record by Lightstone Ventures (A), LP (LV(A) LP). LSV Associates, the General Partner of LV(A) LP, and Mr. Carusi, Ms. George and Mr. Plain, the individual managing directors of LSV Associates, share voting and dispositive power with respect to the shares held of record by LV(A) LP, but each disclaims beneficial ownership of such shares except to the extent of his, her or its individual pecuniary interest therein.
(8) The shares are held of record by Lightstone Ventures II, LP (LV II LP). LSV Associates II, LLC (LSV Associates II), the General Partner of LV II LP, and Mr. Carusi, Ms. George, Mr. Plain and Jason W. Lettmann, as the individual managing directors of LSV Associates II, share voting and dispositive power with respect to the shares held of record by LV II LP, but each disclaims beneficial ownership of such shares except to the extent of his, her or its individual pecuniary interest therein. Mr. Lettmann is a director of the Issuer and files separate Section 16 reports.
(9) Includes 146,485 shares of Common Stock issued as payment of accrued dividends upon conversion of the preferred stock on July 21, 2020.
(10) The shares are held of record by Lightstone Ventures II, LP (LV II(A) LP). LSV Associates II, LLC (LSV Associates II), the General Partner of LV(A) II LP, and Mr. Carusi, Ms. George, Mr. Plain and Mr. Lettmann, as the individual managing directors of LSV Associates II, share voting and dispositive power with respect to the shares held of record by LV II(A) LP, but each disclaims beneficial ownership of such shares except to the extent of his, her or its individual pecuniary interest therein. Mr. Lettmann is a director of the Issuer and files separate Section 16 reports.
(11) Includes 8,684 shares of Common Stock issued as payment of accrued dividends upon conversion of the preferred stock on July 21, 2020.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
LSV Associates, LLC
C/O LSV CAPITAL MANAGEMENT, LLC
2884 SAND HILL ROAD, SUITE 121
MENLO PARK, CA 94025

X

Lightstone Ventures, L.P.
C/O LSV CAPITAL MANAGEMENT, LLC
2884 SAND HILL ROAD, SUITE 121
MENLO PARK, CA 

X

Lightstone Ventures (A), L.P.
C/O LSV CAPITAL MANAGEMENT, LLC
2884 SAND HILL ROAD, SUITE 121
MENLO PARK, CA 94025

X

Lightstone Ventures II, L.P.
C/O LSV CAPITAL MANAGEMENT, LLC
2884 SAND HILL ROAD, SUITE 121
MENLO PARK, CA 94025

X

Lightstone Ventures II (A), L.P.
C/O LSV CAPITAL MANAGEMENT, LLC
2884 SAND HILL ROAD, SUITE 121
MENLO PARK, CA 94025

X

LSV Associates II, LLC
C/O LSV CAPITAL MANAGEMENT, LLC
2884 SAND HILL ROAD, SUITE 121
MENLO PARK, CA 94025

X

Carusi Michael A
C/O LSV CAPITAL MANAGEMENT, LLC
2884 SAND HILL ROAD, SUITE 121
MENLO PARK, CA 94025

X

George Jean
C/O LSV CAPITAL MANAGEMENT, LLC
2884 SAND HILL ROAD, SUITE 121
MENLO PARK, CA 94025

X

Plain Henry A JR
C/O LSV CAPITAL MANAGEMENT, LLC
2884 SAND HILL ROAD, SUITE 121
MENLO PARK, CA 94025

X


Signatures
/s/ Travis Boettner, by power of attorney for LSV Associates, LLC, the General Partner of Lightstone Ventures, L.P.7/21/2020
**Signature of Reporting PersonDate

/s/ Travis Boettner, by power of attorney for LSV Associates, LLC, the General Partner of Lightstone Ventures(A), L.P.7/21/2020
**Signature of Reporting PersonDate

/s/ Travis Boettner, by power of attorney for LSV Associates, LLC7/21/2020
**Signature of Reporting PersonDate

/s/ Travis Boettner, by power of attorney for LSV Associates II, LLC, the General Partner of Lightstone Ventures II, L.P.7/21/2020
**Signature of Reporting PersonDate

/s/ Travis Boettner, by power of attorney for LSV Associates II, LLC, the General Partner of Lightstone Ventures II(A), L.P.7/21/2020
**Signature of Reporting PersonDate

/s/ Travis Boettner, by power of attorney for LSV Associates II, LLC7/21/2020
**Signature of Reporting PersonDate

/s/ Travis Boettner, by power of attorney for Michael A. Carusi7/21/2020
**Signature of Reporting PersonDate

/s/ Travis Boettner, by power of attorney for Jean M. George7/21/2020
**Signature of Reporting PersonDate

/s/ Travis Boettner, by power of attorney for Henry A. Plain, Jr.7/21/2020
**Signature of Reporting PersonDate

ALX Oncology (NASDAQ:ALXO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more ALX Oncology Charts.
ALX Oncology (NASDAQ:ALXO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more ALX Oncology Charts.